We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TSVT market cap is 252.45M. The company's latest EPS is USD -4.2402 and P/E is -1.13.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 56.18M | 41.62M | 36.05M | 12.03M | 10.68M |
| Operating Income | -58.62M | -51.64M | -47.94M | -78.09M | -59.88M |
| Net Income | -23.14M | -47.02M | -42.09M | -71.64M | -56.82M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 54.52M | 91.5M | 100.39M |
| Operating Income | -313.51M | -262.91M | -237.37M |
| Net Income | -292.21M | -254.15M | -217.57M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Total Assets | 656.67M | 742.44M | 705.71M | 640.81M | 565.43M |
| Total Liabilities | 346.2M | 341.11M | 338.22M | 334.38M | 310.13M |
| Total Equity | 310.47M | 401.32M | 367.5M | 306.42M | 255.3M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 759.68M | 656.67M | 565.43M |
| Total Liabilities | 399.85M | 346.2M | 310.13M |
| Total Equity | 359.82M | 310.47M | 255.3M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |||
| Operating | -237.13M | -49.09M | -81.75M | -103.26M | -166.86M |
| Investing | 11.7M | 44.8M | -20.08M | -4.03M | 43.86M |
| Financing | 166.23M | 127.08M | 127.21M | 127.14M | 127.39M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Operating | -207.03M | -237.13M | -166.86M |
| Investing | 15.41M | 11.7M | 43.86M |
| Financing | 354.89M | 166.23M | 127.39M |
| Market Cap | 252.45M |
| Price to Earnings Ratio | -1.13 |
| Price to Sales Ratio | 2.45 |
| Price to Cash Ratio | 3.29 |
| Price to Book Ratio | 0.96 |
| Dividend Yield | - |
| Shares Outstanding | 51.31M |
| Average Volume (1 week) | 360.94k |
| Average Volume (1 Month) | 637.05k |
| 52 Week Change | -55.52% |
| 52 Week High | 12.69 |
| 52 Week Low | 1.535 |
| Spread (Intraday) | 0.23 (4.67%) |
| Company Name | 2seventy bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.2seventybio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
